82 related articles for article (PubMed ID: 7602375)
41. [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside].
Patterson D; Kravtsova VM; Petrova EM; Zabelina TS; Balaian LN
Ter Arkh; 1987; 59(12):81-6. PubMed ID: 3482131
[TBL] [Abstract][Full Text] [Related]
42. Treatment of acute myelogenous leukemia in the elderly.
Champlin RE; Gajewski JL; Golde DW
Semin Oncol; 1989 Feb; 16(1):51-6. PubMed ID: 2645650
[TBL] [Abstract][Full Text] [Related]
43. A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75.
Reiffers J; Huguet F; Stoppa AM; Molina L; Marit G; Attal M; Gastaut JA; Michallet M; Lepeu G; Broustet A; Pris J; Maraninchi D; Hollard D; Fabères C; Mercier M; Hurteloup P; Danel P; Tellier Z; Berthaud P
Leukemia; 1996 Mar; 10(3):389-95. PubMed ID: 8642852
[TBL] [Abstract][Full Text] [Related]
44. Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm.
Walter RB; Othus M; Orlowski KF; McDaniel EN; Scott BL; Becker PS; Percival MM; Hendrie PC; Medeiros BC; Chiarella MT; Louie AC; Estey EH
Haematologica; 2018 Mar; 103(3):e106-e109. PubMed ID: 29242304
[No Abstract] [Full Text] [Related]
45. A historical perspective on the development of the cytarabine (7days) and daunorubicin (3days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7+3.
Lichtman MA
Blood Cells Mol Dis; 2013 Feb; 50(2):119-30. PubMed ID: 23154039
[TBL] [Abstract][Full Text] [Related]
46. Usefulness of bone-marrow biopsy during induction therapy for acute myeloid leukemia.
Shamdas GJ; Garewal HS; Roe DJ
Lancet; 1992 Jan; 339(8786):178. PubMed ID: 1346026
[No Abstract] [Full Text] [Related]
47. Acute myelogenous leukemia in pregnancy.
Cantini E; Yanes B
South Med J; 1984 Aug; 77(8):1050-2. PubMed ID: 6589786
[TBL] [Abstract][Full Text] [Related]
48. Intensive timed chemotherapy for 51 acute myeloid leukemia patients with poor prognosis.
Fiere D; Campos L; Coiffier B; Extra JM; Ffrench M; Guyotat D; Ritouet D; Huan VV
Semin Oncol; 1985 Jun; 12(2 Suppl 3):130-2. PubMed ID: 3859926
[No Abstract] [Full Text] [Related]
49. [Acute myelogenous leukemia in elderly].
Mori M
Rinsho Ketsueki; 1999 Feb; 40(2):77-80. PubMed ID: 10199195
[No Abstract] [Full Text] [Related]
50. Toward Personalization of Cytarabine Dosing in Acute Myeloid Leukemia.
Jordheim LP
J Clin Oncol; 2022 Mar; 40(7):784-786. PubMed ID: 35025625
[No Abstract] [Full Text] [Related]
51. Are we curing acute myelogenous leukemia?
Ben-Bassat I; Bandini G; Rosti G; Gale RP
Leuk Res; 1993 Dec; 17(12):1071-2. PubMed ID: 8246611
[No Abstract] [Full Text] [Related]
52. Re: Pseudorelapse in acute myelomonocytic leukemia after high dose methylprednisolone.
Basade M; Kulkarni S; Advani SH
Leuk Res; 1995 Mar; 19(3):227. PubMed ID: 7700084
[No Abstract] [Full Text] [Related]
53. Treatment of AGL.
Crosby WH
Arch Intern Med; 1969 Feb; 123(2):206-7. PubMed ID: 5249564
[No Abstract] [Full Text] [Related]
54. Prognostic factors in acute myelogenous leukemia.
Cevreska L; Gale RP
Haematol Blood Transfus; 1987; 30():376-9. PubMed ID: 3476370
[No Abstract] [Full Text] [Related]
55. Beyond Survival: The US Food and Drug Administration Confirms Surrogate End Points for Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Intensive Chemotherapy.
DiNardo CD; Pollyea DA
J Clin Oncol; 2022 Mar; 40(8):811-813. PubMed ID: 35007124
[No Abstract] [Full Text] [Related]
56. Prognosis of acute myelogenous leukemia.
Lahuerta-Palacios JJ; Larregla-Garraus S; Fernández-Debora F; Ruiz de Adana R
Ann Intern Med; 1982 Jul; 97(1):140. PubMed ID: 6953778
[No Abstract] [Full Text] [Related]
57. SNPing away to individualize induction therapy for acute myelogenous leukemia.
Kaplan JB; Altman JK; Platanias LC
Leuk Lymphoma; 2016; 57(4):742-3. PubMed ID: 26784362
[No Abstract] [Full Text] [Related]
58. Long survival in acute myelogenous leukaemia.
Lucie NP; Dagg JH; Prentice AG; Smith AG
Br Med J (Clin Res Ed); 1981 May; 282(6274):1472. PubMed ID: 6784869
[No Abstract] [Full Text] [Related]
59. Long survival in acute myelogenous leukaemia.
Freeman CB; Harris R; Taylor GM
Br Med J (Clin Res Ed); 1981 Jul; 283(6284):139. PubMed ID: 6789937
[No Abstract] [Full Text] [Related]
60. Dose-intensive treatment of acute myelogenous leukemia: improved survival?
Schiller G
J Clin Oncol; 1995 Jul; 13(7):1828-30. PubMed ID: 7602375
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
